Michael Buckley

1.2k total citations
34 papers, 919 citations indexed

About

Michael Buckley is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Buckley has authored 34 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Buckley's work include Melanoma and MAPK Pathways (5 papers), Ethics in Clinical Research (5 papers) and Vitamin D Research Studies (3 papers). Michael Buckley is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Ethics in Clinical Research (5 papers) and Vitamin D Research Studies (3 papers). Michael Buckley collaborates with scholars based in United States, Australia and Switzerland. Michael Buckley's co-authors include Larz S.W. Spångberg, Bauer E. Sumpio, Leonard Liebes, A.J. Banes, Félix Bronner, George Johnson, Albert J. Banes, Bruce Ng, Yi He Ling and Jian Jiang and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Michael Buckley

32 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Buckley United States 12 412 189 161 132 117 34 919
Takeo Fujii United States 17 301 0.7× 509 2.7× 70 0.4× 266 2.0× 99 0.8× 76 1.3k
Yong‐Kie Wong Taiwan 24 470 1.1× 434 2.3× 94 0.6× 280 2.1× 440 3.8× 42 1.5k
H Tanzawa Japan 22 891 2.2× 374 2.0× 55 0.3× 138 1.0× 143 1.2× 40 1.5k
Rui Caetano Oliveira Portugal 15 172 0.4× 223 1.2× 68 0.4× 100 0.8× 148 1.3× 98 719
Yong Zhong China 18 378 0.9× 171 0.9× 31 0.2× 319 2.4× 56 0.5× 76 1.0k
Jesús Romero Spain 16 364 0.9× 340 1.8× 39 0.2× 335 2.5× 193 1.6× 62 1.0k
Jonathan H. Shanks United Kingdom 16 360 0.9× 123 0.7× 14 0.1× 246 1.9× 195 1.7× 25 948
Edward L. Lee United States 21 274 0.7× 231 1.2× 34 0.2× 330 2.5× 502 4.3× 49 1.3k
Kyosuke Hatsushika Japan 16 213 0.5× 162 0.9× 14 0.1× 95 0.7× 74 0.6× 23 924

Countries citing papers authored by Michael Buckley

Since Specialization
Citations

This map shows the geographic impact of Michael Buckley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Buckley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Buckley more than expected).

Fields of papers citing papers by Michael Buckley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Buckley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Buckley. The network helps show where Michael Buckley may publish in the future.

Co-authorship network of co-authors of Michael Buckley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Buckley. A scholar is included among the top collaborators of Michael Buckley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Buckley. Michael Buckley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seier, Kenneth, Erin M. Bange, Allison Lipitz‐Snyderman, et al.. (2025). Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine. JCO Oncology Practice. 21(10). 1439–1446. 1 indexed citations
2.
Buckley, Michael, et al.. (2024). Defining methods to improve eSource site start-up practices. Contemporary Clinical Trials Communications. 42. 101391–101391.
3.
4.
Buckley, Michael, Allison Lipitz‐Snyderman, Gilad J. Kuperman, et al.. (2022). Digitalizing the Clinical Research Informed Consent Process: Assessing the Participant Experience in Comparison With Traditional Paper-Based Methods. JCO Oncology Practice. 19(3). e355–e364. 3 indexed citations
5.
Buckley, Michael, Allison Lipitz‐Snyderman, Gilad J. Kuperman, et al.. (2022). Electronic research consents for complex early-phase I-II clinical trials integrated with telemedicine visits compared with in-person encounters.. Journal of Clinical Oncology. 40(16_suppl). 1514–1514. 1 indexed citations
6.
7.
Buckley, Michael, et al.. (2014). Targeted amplification of delivery to cell surface receptors by dendrimer self-assembly. Bioorganic & Medicinal Chemistry Letters. 24(5). 1290–1293. 2 indexed citations
8.
Ott, Patrick A., Anne Hamilton, Herman Yee, et al.. (2010). A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates. PLoS ONE. 5(12). e15588–e15588. 80 indexed citations
9.
Yu, Jessie Z., Melanie Warycha, Paul J. Christos, et al.. (2008). Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients. Journal of Translational Medicine. 6(1). 70–70. 9 indexed citations
10.
Cai, Chao, Yi Peng, Michael Buckley, et al.. (2008). Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations. Oncogene. 27(22). 3201–3210. 31 indexed citations
11.
Buckley, Michael, Herman Yee, Luis Chiriboga, et al.. (2007). The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo. Journal of Translational Medicine. 5(1). 49–49. 66 indexed citations
12.
Xavier, Sandhya, Jennifer Roth, Maresa Caunt, et al.. (2006). The vitamin-like dietary supplement para-aminobenzoic acid enhances the antitumor activity of ionizing radiation. International Journal of Radiation Oncology*Biology*Physics. 65(2). 517–527. 18 indexed citations
13.
Liebes, Leonard, Franco M. Muggia, Anne C. Pavlick, et al.. (2006). Continuous intravenous infusion (CIVI) topotecan may be safely combined with tipifarnib. Journal of Clinical Oncology. 24(18_suppl). 2064–2064. 1 indexed citations
14.
Pavlick, Anna C., Leonard Liebes, Iman Osman, et al.. (2006). Sorafenib down-regulation of the RAS/BRAF/MEK/MAPK pathway: clinical, pathologic and PET correlation. Melanoma Research. 16(Supplement 1). S96–S97. 1 indexed citations
15.
Liebes, Leonard, David T. Levy, Elizabeth Poplin, et al.. (2006). Gemcitabine (G) plamsa and intracellular pharmacokinetics in E6201: Greater metabolite levels using fixed dosing rate (FDR) delivery. Journal of Clinical Oncology. 24(18_suppl). 2024–2024. 1 indexed citations
16.
Buckley, Michael, David Newman, Leonard Liebes, et al.. (2005). Para-aminobenzoic acid (PABA) enhances the in-vitro tumor response of ovarian cancer to Topotecan (TTN) through mitochondrial-mediated apoptosis. Cancer Research. 65. 1258–1258. 3 indexed citations
17.
Recht, Phoebe A., et al.. (2004). Oxalic acid alters intracellular calcium in endothelial cells. Atherosclerosis. 173(2). 319–326. 32 indexed citations
18.
Ziccardi, Vincent B., Thomas Braun, & Michael Buckley. (1996). Relationship of the Infraorbital Nerve and Vessels in the Pathogenesis of Idiopathic Trigeminal Neuralgia: A Theoretical Discussion and Cadaveric Study. CRANIO®. 14(2). 114–120. 1 indexed citations
19.
Buckley, Michael & Larz S.W. Spångberg. (1995). The prevalence and technical quality of endodontic treatment in an American subpopulation. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 79(1). 92–100. 166 indexed citations
20.
Bronner, F., et al.. (1982). Molecular and transport effects of 1,25-dihydroxyvitamin D3 in rat duodenum.. PubMed. 41(1). 61–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeo Fujii Breakdown of academic impact, for papers by Yong‐Kie Wong Breakdown of academic impact, for papers by H Tanzawa Breakdown of academic impact, for papers by Rui Caetano Oliveira Breakdown of academic impact, for papers by Yong Zhong Breakdown of academic impact, for papers by Jesús Romero Breakdown of academic impact, for papers by Jonathan H. Shanks Breakdown of academic impact, for papers by Edward L. Lee Breakdown of academic impact, for papers by Kyosuke Hatsushika
Rankless by CCL
2026